Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis

Published:2008-01-03 Issue:4 Volume:27 Page:511-513
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Alexiou Ioannis,Germenis Anastasios,Koutroumpas Athanasios,Kontogianni Anastasia,Theodoridou Katerina,Sakkas Lazaros I.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-007-0800-1.pdf

Reference17 articles.

1. Gabriel SE, Crowson CS, Kremers HM et al (2003) Survival in rheumatoid arthritis. A population-based analysis of trends over 40 years. Arthritis Rheum 48:54–8

2. Ronnelid J, Wick MC, Lampa J et al (2005) Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CCP) during 5 year follow up in early rheumatoid arthritis: anti-CCP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 64:1744–49

3. Turesson C, Jacobsson LTH, Sturfelt G et al (2007) Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis 66:59–64

4. van Gaalen FA, van Aken J, Huizinga TWJ et al (2004) Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influence the severity of rheumatoid arthritis. Arthritis Rheum 50:2113–21

5. Van der Helm-van Mil AH, Verpoort KN, Breedveld FC et al (2006) The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor to develop rheumatoid arthritis. Arthritis Rheum 54:1117–21

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using thoracic ultrasound to detect interstitial lung disease in patients with rheumatoid arthritis: a protocol for the diagnostic test accuracy AURORA study;BMJ Open;2022-12

2. Development of a Risk Nomogram Model for Identifying Interstitial Lung Disease in Patients With Rheumatoid Arthritis;Frontiers in Immunology;2022-06-16

3. Predictors of long-term prognosis in rheumatoid arthritis-related interstitial lung disease;Scientific Reports;2022-06-08

4. Current issues in rheumatoid arthritis-associated interstitial lung disease;The Lancet Rheumatology;2021-11

5. Análisis de las características clínico-analíticas de pacientes con artritis reumatoide y enfermedad pulmonar intersticial: casos y controles;Reumatología Clínica;2021-04